Skip navigation
  • Sciety Labs 🧪 (Experimental)
  • Search
Sciety application utilities

Immunology

  • Subscribe to feed (RSS)

Showing page 150 of 175 pages of list content

  • Differential roles of RIG-I-like receptors in SARS-CoV-2 infection

    This article's authors
    1. Duomeng Yang
    2. Tingting Geng
    3. Andrew G. Harrison
    4. Penghua Wang
    This article has 1 evaluations Latest evaluation on Feb 14, 2021 Published on Feb 11, 2021
  • Limited window for donation of convalescent plasma with high live-virus neutralizing antibodies for COVID-19 immunotherapy

    This article's authors
    1. Abhinay Gontu
    2. Sreenidhi Srinivasan
    3. Eric Salazar
    4. Meera Surendran Nair
    5. Ruth H. Nissly
    6. Denver Greenawalt
    7. Ian M. Bird
    8. Catherine Herzog
    9. Matthew J. Ferrari
    10. Indira Poojary
    11. Robab Katani
    12. Scott E. Lindner
    13. Allen M. Minns
    14. Randall Rossi
    15. Paul A. Christensen
    16. Brian Castillo
    17. Jian Chen
    18. Todd N. Eagar
    19. Xin Yi
    20. Picheng Zhao
    21. Christopher Leveque
    22. Randall J. Olsen
    23. David W. Bernard
    24. Jimmy Gollihar
    25. Suresh V. Kuchipudi
    26. James M. Musser
    27. Vivek Kapur
    This article has 1 evaluations Latest evaluation on Mar 1, 2021 Published on Aug 21, 2020
  • An autocrine Vitamin D-driven Th1 shutdown program can be exploited for COVID-19

    This article's authors
    1. Reuben McGregor
    2. Daniel Chauss
    3. Tilo Freiwald
    4. Bingyu Yan
    5. Luopin Wang
    6. Estefania Nova-Lamperti
    7. Zonghao Zhang
    8. Heather Teague
    9. Erin E West
    10. Jack Bibby
    11. Audrey Kelly
    12. Amna Malik
    13. Alexandra F Freeman
    14. Daniella Schwartz
    15. Didier Portilla
    16. Susan John
    17. Paul Lavender
    18. Michail S Lionakis
    19. Nehal N Mehta
    20. Claudia Kemper
    21. Nichola Cooper
    22. Giovanna Lombardi
    23. Arian Laurence
    24. Majid Kazemian
    25. Behdad Afzali
    This article has 2 evaluations Latest evaluation on Mar 1, 2021 Published on Jul 19, 2020
  • Neural epidermal growth factor-like 1 protein variant increases survival and modulates the inflammatory and immune responses in human ACE-2 transgenic mice infected with SARS-CoV-2

    This article's authors
    1. Roopa Biswas
    2. Shannon Eaker
    3. Dharmendra Kumar Soni
    4. Swagata Kar
    5. Denae LoBato
    6. Cymbeline Culiat
    This article has 1 evaluations Latest evaluation on Mar 1, 2021 Published on Feb 8, 2021
  • A novel antibody against the furin cleavage site of SARS-CoV-2 spike protein: effects on proteolytic cleavage and ACE2 binding

    This article's authors
    1. Michael G. Spelios
    2. Jeanne M. Capanelli
    3. Adam W. Li
    This article has 1 evaluations Latest evaluation on Mar 1, 2021 Published on Feb 9, 2021
  • A single-cell atlas of lymphocyte adaptive immune repertoires and transcriptomes reveals age-related differences in convalescent COVID-19 patients

    This article's authors
    1. Florian Bieberich
    2. Rodrigo Vazquez-Lombardi
    3. Alexander Yermanos
    4. Roy A. Ehling
    5. Derek M. Mason
    6. Bastian Wagner
    7. Edo Kapetanovic
    8. Raphael Brisset Di Roberto
    9. Cédric R. Weber
    10. Miodrag Savic
    11. Fabian Rudolf
    12. Sai T. Reddy
    This article has 1 evaluations Latest evaluation on Mar 1, 2021 Published on Feb 15, 2021
  • Allelic variation in Class I HLA determines pre-existing memory responses to SARS-CoV-2 that shape the CD8 + T cell repertoire upon viral exposure

    This article's authors
    1. Joshua M. Francis
    2. Del Leistritz-Edwards
    3. Augustine Dunn
    4. Christina Tarr
    5. Jesse Lehman
    6. Conor Dempsey
    7. Andrew Hamel
    8. Violeta Rayon
    9. Gang Liu
    10. Yuntong Wang
    11. Marcos Wille
    12. Melissa Durkin
    13. Kane Hadley
    14. Aswathy Sheena
    15. Benjamin Roscoe
    16. Mark Ng
    17. Graham Rockwell
    18. Margaret Manto
    19. Elizabeth Gienger
    20. Joshua Nickerson
    21. MGH COVID-19 Collection and Processing Team
    22. Amir Moarefi
    23. Michael Noble
    24. Thomas Malia
    25. Philip D. Bardwell
    26. William Gordon
    27. Joanna Swain
    28. Mojca Skoberne
    29. Karsten Sauer
    30. Tim Harris
    31. Ananda W. Goldrath
    32. Alex K. Shalek
    33. Anthony J. Coyle
    34. Christophe Benoist
    35. Daniel C. Pregibon
    This article has 1 evaluations Latest evaluation on May 2, 2021 Published on Apr 29, 2021
  • Scalable, Micro-Neutralization Assay for Qualitative Assessment of SARS-CoV-2 (COVID-19) Virus-Neutralizing Antibodies in Human Clinical Samples

    This article's authors
    1. Richard S. Bennett
    2. Elena N. Postnikova
    3. Janie Liang
    4. Robin Gross
    5. Steven Mazur
    6. Saurabh Dixit
    7. Vladimir V. Lukin
    8. Greg Kocher
    9. Shuiqing Yu
    10. Shalamar Georgia-Clark
    11. Dawn Gerhardt
    12. Yingyun Cai
    13. Lindsay Marron
    14. Michael R. Holbrook
    This article has 1 evaluations Latest evaluation on Mar 15, 2021 Published on Mar 5, 2021
  • A single BNT162b2 mRNA dose elicits antibodies with Fc-mediated effector functions and boost pre-existing humoral and T cell responses

    This article's authors
    1. Alexandra Tauzin
    2. Manon Nayrac
    3. Mehdi Benlarbi
    4. Shang Yu Gong
    5. Romain Gasser
    6. Guillaume Beaudoin-Bussières
    7. Nathalie Brassard
    8. Annemarie Laumaea
    9. Dani Vézina
    10. Jérémie Prévost
    11. Sai Priya Anand
    12. Catherine Bourassa
    13. Gabrielle Gendron-Lepage
    14. Halima Medjahed
    15. Guillaume Goyette
    16. Julia Niessl
    17. Olivier Tastet
    18. Laurie Gokool
    19. Chantal Morrisseau
    20. Pascale Arlotto
    21. Leonidas Stamatatos
    22. Andrew T. McGuire
    23. Catherine Larochelle
    24. Pradeep Uchil
    25. Maolin Lu
    26. Walther Mothes
    27. Gaston De Serres
    28. Sandrine Moreira
    29. Michel Roger
    30. Jonathan Richard
    31. Valérie Martel-Laferrière
    32. Ralf Duerr
    33. Cécile Tremblay
    34. Daniel E. Kaufmann
    35. Andrés Finzi
    This article has 1 evaluations Latest evaluation on Mar 24, 2021 Published on Mar 18, 2021
  • Limiting the priming dose of a SARS CoV-2 vaccine improves virus-specific immunity

    This article's authors
    1. Sarah Sanchez
    2. Nicole Palacio
    3. Tanushree Dangi
    4. Thomas Ciucci
    5. Pablo Penaloza-MacMaster
    This article has 1 evaluations Latest evaluation on Apr 3, 2021 Published on Apr 1, 2021
Previous Next
Stay updated. Get involved.
Subscribe to Mailing List
  • Blog
  • About Sciety
  • Contact
  • Follow us on Twitter
  • Follow us on Facebook
© 2022 eLife Sciences Publications Ltd. Legal information